Skip to main content
Erschienen in: Acta Neurochirurgica 1/2023

23.12.2022 | Original Article - Spine - Other

Impact of preoperative symptom duration in patients undergoing lateral lumbar interbody fusion

verfasst von: James W. Nie, Timothy J. Hartman, Omolabake O. Oyetayo, Keith R. MacGregor, Eileen Zheng, Alexander W. Parsons, Dustin H. Massel, Arash J. Sarari, Kern Singh

Erschienen in: Acta Neurochirurgica | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Few studies have examined the influence of preoperative symptom duration on clinical outcomes in patients undergoing lateral lumbar interbody fusion (LLIF) for degenerative conditions.

Methods

Patients undergoing LLIF presenting with radiculopathy and/or neurogenic claudication were separated into two groups: preoperative symptom duration < 1-year (shorter duration) versus duration ≥ 1-year (longer duration). Patients undergoing surgery for trauma/malignancy/infection were excluded. Patient-reported outcome measures (PROMs) of Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS-PF), 12-Item Short Form Physical/Mental Component Score (SF-12 PCS/MCS), Patient Health Questionnaire-9 (PHQ-9), visual analog scale (VAS) back/leg, and Oswestry Disability Index (ODI) were collected at preoperative and postoperative time points.

Results

Eighty-two total patients, with 34 shorter-duration patients, were identified after propensity score matching for demographics. Longer-duration patients had higher estimated blood loss. All patients reported significant improvement in physical function, mental function, pain, and disability in at least one postoperative time point, except for SF-12 MCS in the shorter duration cohort. The longer duration cohort had higher MCID achievement in 12-week VAS back.

Conclusion

Patients undergoing LLIF demonstrated significant postoperative improvement in physical function, mental function, pain, and disability outcomes independent of preoperative symptom duration. Both cohorts, when compared by preoperative symptom duration, demonstrated similar postoperative PROM scores. Patients with longer preoperative symptom duration had higher 12-week leg pain MCID achievement. These findings suggest that delayed time to surgery may not lead to inferior clinical outcomes in patients undergoing LLIF for degenerative conditions.
Literatur
1.
Zurück zum Zitat Alentado VJ, Lubelski D, Steinmetz MP, Benzel EC, Mroz TE (2014) Optimal duration of conservative management prior to surgery for cervical and lumbar radiculopathy: a literature review. Global Spine J 4(4):279–286CrossRef Alentado VJ, Lubelski D, Steinmetz MP, Benzel EC, Mroz TE (2014) Optimal duration of conservative management prior to surgery for cervical and lumbar radiculopathy: a literature review. Global Spine J 4(4):279–286CrossRef
2.
Zurück zum Zitat Alluri R, Mok JK, Vaishnav A et al (2021) Intraoperative neuromonitoring during lateral lumbar interbody fusion. Neurospine 18(3):430–436CrossRef Alluri R, Mok JK, Vaishnav A et al (2021) Intraoperative neuromonitoring during lateral lumbar interbody fusion. Neurospine 18(3):430–436CrossRef
3.
Zurück zum Zitat Basques BA, Haws BE, Khechen B et al (2019) The effect of preoperative symptom duration on postoperative outcomes after a tubular lumbar microdiscectomy. Clin Spine Surg 32(1):E27–E30CrossRef Basques BA, Haws BE, Khechen B et al (2019) The effect of preoperative symptom duration on postoperative outcomes after a tubular lumbar microdiscectomy. Clin Spine Surg 32(1):E27–E30CrossRef
4.
Zurück zum Zitat Cushnie D, Thomas K, Jacobs WB et al (2019) Effect of preoperative symptom duration on outcome in lumbar spinal stenosis: a Canadian Spine Outcomes and Research Network registry study. Spine J 19(9):1470–1477CrossRef Cushnie D, Thomas K, Jacobs WB et al (2019) Effect of preoperative symptom duration on outcome in lumbar spinal stenosis: a Canadian Spine Outcomes and Research Network registry study. Spine J 19(9):1470–1477CrossRef
5.
Zurück zum Zitat De la Garza-Ramos R, Ramhmdani S, Kosztowski T et al (2017) Prognostic value of preoperative Nurick grade and time with symptoms in patients with cervical myelopathy and gait impairment. World Neurosurg 105:314–320CrossRef De la Garza-Ramos R, Ramhmdani S, Kosztowski T et al (2017) Prognostic value of preoperative Nurick grade and time with symptoms in patients with cervical myelopathy and gait impairment. World Neurosurg 105:314–320CrossRef
6.
Zurück zum Zitat Ebersold MJ, Pare MC, Quast LM (1995) Surgical treatment for cervical spondylitic myelopathy. J Neurosurg 82(5):745–751CrossRef Ebersold MJ, Pare MC, Quast LM (1995) Surgical treatment for cervical spondylitic myelopathy. J Neurosurg 82(5):745–751CrossRef
7.
Zurück zum Zitat Hamawandi SA, Sulaiman II, Abdulhameed AM (2022) Effect of duration of symptoms on the clinical and functional outcomes of lumbar microdiscectomy: a randomized controlled trial. Orthop Surg 14(1):157–168CrossRef Hamawandi SA, Sulaiman II, Abdulhameed AM (2022) Effect of duration of symptoms on the clinical and functional outcomes of lumbar microdiscectomy: a randomized controlled trial. Orthop Surg 14(1):157–168CrossRef
8.
Zurück zum Zitat Hung M, Saltzman CL, Kendall R et al (2018) What are the MCIDs for PROMIS, NDI, and ODI instruments among patients with spinal conditions? Clin Orthop Relat Res 476(10):2027–2036CrossRef Hung M, Saltzman CL, Kendall R et al (2018) What are the MCIDs for PROMIS, NDI, and ODI instruments among patients with spinal conditions? Clin Orthop Relat Res 476(10):2027–2036CrossRef
9.
Zurück zum Zitat Joseph JR, Smith BW, La Marca F, Park P (2015) Comparison of complication rates of minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion: a systematic review of the literature. Neurosurg Focus 39(4):E4CrossRef Joseph JR, Smith BW, La Marca F, Park P (2015) Comparison of complication rates of minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion: a systematic review of the literature. Neurosurg Focus 39(4):E4CrossRef
10.
Zurück zum Zitat Kim CH, Easley K, Lee JS et al (2020) Comparison of minimally invasive versus open transforaminal interbody lumbar fusion. Global Spine J 10(2 Suppl):143S-150SCrossRef Kim CH, Easley K, Lee JS et al (2020) Comparison of minimally invasive versus open transforaminal interbody lumbar fusion. Global Spine J 10(2 Suppl):143S-150SCrossRef
11.
Zurück zum Zitat Lynch CP, Cha EDK, Jenkins NW et al (2021) The minimum clinically important difference for patient health questionnaire-9 in minimally invasive transforaminal interbody fusion. Spine 46(9):603–609CrossRef Lynch CP, Cha EDK, Jenkins NW et al (2021) The minimum clinically important difference for patient health questionnaire-9 in minimally invasive transforaminal interbody fusion. Spine 46(9):603–609CrossRef
12.
Zurück zum Zitat Mobbs RJ, Phan K, Malham G, Seex K, Rao PJ (2015) Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP. LLIF and ALIF J Spine Surg 1(1):2–18 Mobbs RJ, Phan K, Malham G, Seex K, Rao PJ (2015) Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP. LLIF and ALIF J Spine Surg 1(1):2–18
13.
14.
Zurück zum Zitat Omidi-Kashani F, GhayemHasankhani E, Kachooei AR, Rahimi MD, Khanzadeh R (2014) Does duration of preoperative sciatica impact surgical outcomes in patients with lumbar disc herniation? Neurol Res Int 2014:565189CrossRef Omidi-Kashani F, GhayemHasankhani E, Kachooei AR, Rahimi MD, Khanzadeh R (2014) Does duration of preoperative sciatica impact surgical outcomes in patients with lumbar disc herniation? Neurol Res Int 2014:565189CrossRef
15.
Zurück zum Zitat Parker SL, Adogwa O, Paul AR et al (2011) Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis. J Neurosurg Spine 14(5):598–604CrossRef Parker SL, Adogwa O, Paul AR et al (2011) Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis. J Neurosurg Spine 14(5):598–604CrossRef
16.
Zurück zum Zitat Radcliff KE, Rihn J, Hilibrand A et al (2011) Does the duration of symptoms in patients with spinal stenosis and degenerative spondylolisthesis affect outcomes?: analysis of the Spine Outcomes Research Trial. Spine 36(25):2197–2210CrossRef Radcliff KE, Rihn J, Hilibrand A et al (2011) Does the duration of symptoms in patients with spinal stenosis and degenerative spondylolisthesis affect outcomes?: analysis of the Spine Outcomes Research Trial. Spine 36(25):2197–2210CrossRef
17.
Zurück zum Zitat Salzmann SN, Shue J, Hughes AP (2017) Lateral lumbar interbody fusion-outcomes and complications. Curr Rev Musculoskelet Med 10(4):539–546CrossRef Salzmann SN, Shue J, Hughes AP (2017) Lateral lumbar interbody fusion-outcomes and complications. Curr Rev Musculoskelet Med 10(4):539–546CrossRef
18.
Zurück zum Zitat Tarazona D, Boody B, Hilibrand AS et al (2019) Longer preoperative duration of symptoms negatively affects health-related quality of life after surgery for cervical radiculopathy. Spine 44(10):685–690CrossRef Tarazona D, Boody B, Hilibrand AS et al (2019) Longer preoperative duration of symptoms negatively affects health-related quality of life after surgery for cervical radiculopathy. Spine 44(10):685–690CrossRef
19.
Zurück zum Zitat Tetreault L, Wilson JR, Kotter MRN et al (2019) Is preoperative duration of symptoms a significant predictor of functional outcomes in patients undergoing surgery for the treatment of degenerative cervical myelopathy? Neurosurgery 85(5):642–647CrossRef Tetreault L, Wilson JR, Kotter MRN et al (2019) Is preoperative duration of symptoms a significant predictor of functional outcomes in patients undergoing surgery for the treatment of degenerative cervical myelopathy? Neurosurgery 85(5):642–647CrossRef
20.
Zurück zum Zitat Yoo JS, Patel DS, Hrynewycz NM, Brundage TS, Mogilevsky FA, Singh K (2020) The effect of preoperative symptom duration on postoperative outcomes after minimally invasive transforaminal lumbar interbody fusion. Clin Spine Surg 33(6):E263–E268CrossRef Yoo JS, Patel DS, Hrynewycz NM, Brundage TS, Mogilevsky FA, Singh K (2020) The effect of preoperative symptom duration on postoperative outcomes after minimally invasive transforaminal lumbar interbody fusion. Clin Spine Surg 33(6):E263–E268CrossRef
Metadaten
Titel
Impact of preoperative symptom duration in patients undergoing lateral lumbar interbody fusion
verfasst von
James W. Nie
Timothy J. Hartman
Omolabake O. Oyetayo
Keith R. MacGregor
Eileen Zheng
Alexander W. Parsons
Dustin H. Massel
Arash J. Sarari
Kern Singh
Publikationsdatum
23.12.2022
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 1/2023
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-022-05436-y

Weitere Artikel der Ausgabe 1/2023

Acta Neurochirurgica 1/2023 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.